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A major obstacle in analyzing gene function in api-
complexan parasites is the absence of a practical
regulatable expression system. Here, we identified
functional transcriptional activation domains within
Apicomplexan AP2 (ApiAP2) family transcription
factors. These ApiAP2 transactivation domains
were validated in blood-, liver-, and mosquito-stage
parasites and used to create a robust conditional
expression system for stage-specific, tetracycline-
dependent gene regulation in Toxoplasma gondii,
Plasmodium berghei, and Plasmodium falciparum.
To demonstrate the utility of this system, we created
conditional knockdowns of two essential P. berghei
genes: profilin (PRF), a protein implicated in parasite
invasion, and N-myristoyltransferase (NMT), which
catalyzes protein acylation. Tetracycline-induced
repression of PRF and NMT expression resulted in
a dramatic reduction in parasite viability. This effi-
cient regulatable system will allow for the functional
characterization of essential proteins that are found
in these important parasites.
INTRODUCTION
Access to a generalizable system that tightly controls gene
expression has been long sought after in molecular malaria
research. In other parasitic organisms, such as Trypanosoma
brucei, RNA interference (RNAi) is widely used in combination
with a tight tetracycline repressor (TetRep)-based system (Bastin
et al., 2000; Wirtz and Clayton, 1995). However, the application
of RNAi-based regulation in the Plasmodium species is not
broadly applicable (Mohmmed et al., 2003), presumably due to
the absence of a complete RNAi machinery (Baum et al.,
2009). An alternative strategy based on the FLP recognition
target (FRT)-specific/FLP recombinase system has been
demonstrated to work in Plasmodium (O’Neill et al., 2011; van
Schaijk et al., 2010), and this system despite its irreversibility,
offers the ability to investigate gene essentiality at restricted824 Cell Host & Microbe 12, 824–834, December 13, 2012 ª2012 Elsdevelopmental stages (Combe et al., 2009). More recently, the
control of protein stability with destabilization fusion domains
has been effectively applied to some P. falciparum genes (Arm-
strong and Goldberg, 2007; Dvorin et al., 2010; Russo et al.,
2009).
In the related apicomplexan parasite Toxoplasma gondii, an
inducible gene expression system was established based on
a transactivator composed of the TetRep fused to a nonendoge-
nous activating domain (TATi1) (Meissner et al., 2002). Despite its
artificial nature (being derived from a normally noncoding
sequence of the plasmid backbone), this element isolated from
a genetic screen in the parasite has proven to be extremely valu-
able to dissect the mechanistic function of numerous essential
T. gondii genes, such as those implicated in invasion (Buguliskis
et al., 2010; Huynh and Carruthers, 2006; Meissner et al., 2002;
Plattner et al., 2008). The transactivator binds via the TetRep to
tet operator sequences (TetO) placed in front of a minimal
promoter and activates transcription. In the presence of tetracy-
cline or the derivative anhydrotetracycline (ATc), the affinity of
the TetRep for the TetO is dramatically reduced and transcription
is turned off (Bujard, 1999; Meissner et al., 2001). However, the
adaptation of TATi-2 to Plasmodium, although successful in
tightly controlling transgene expression frommulticopy episomal
plasmids (Meissner et al., 2005), failed to find utility for the
construction of conditional knockouts both in P. falciparum
and P. berghei, probably due to insufficient transactivation
activity (three attempts to conditionally KO Pbprf failed with
TATi2, whereas all the attempts with the transactivators identi-
fied in this study were successful; data not shown). We reasoned
that a transactivation system for Plasmodium spp. could best be
designed by relying on the parasite’s own machinery for tran-
scriptional activation.
Despite extensive bioinformatic analyses focusing mainly on
sequence similarity to known eukaryotic transcription factors,
the phylum Apicomplexa has presented a paucity of transcrip-
tion factors (Balaji et al., 2005; Bischoff and Vaquero, 2010; Call-
ebaut et al., 2005). Recently, however, a group of conserved
proteins containing putative Apetala2 DNA-binding domains,
now known as the Apicomplexan Apetala2 (ApiAP2) protein
family, have been described (Balaji et al., 2005). The
P. falciparum genome encodes 27 ApiAP2 proteins, some of
which function as specific transcription factors to regulate
progression throughout the parasite life cycle (Painter et al.,evier Inc.
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copies of the signature 60 amino acid AP2 DNA binding domain,
and, collectively, several studies have characterized the DNA
binding specificities for the P. falciparum ApiAP2 family
members (Campbell et al., 2010; De Silva et al., 2008; Flueck
et al., 2010; Lindner et al., 2010; Llina´s et al., 2008). In
P. berghei, the ApiAP2 transcriptional regulators AP2-O and
AP2-Sp have been functionally analyzed in the nonerythrocytic
ookinete and sporozoite life stages, respectively, and were
found to serve as master regulators of parasite development in
the mosquito (Yuda et al., 2010; Yuda et al., 2009). However,
no functional domains have been recognized outside of the
DNA binding domain for any ApiAP2 protein to date.
RESULTS AND DISCUSSION
Identifying ApiAP2 Protein Fragments that Activate
Transcription
To identify transactivating regions within ApiAP2 proteins, we
used the genetically tractable models yeast and T. gondii to
more rapidly screen for active protein sequences. First, with
a one-hybrid approach in Saccharomyces cerevisiae (Fields
and Song, 1989), three ApiAP2 proteins from P. falciparum,
PFF0200c/PfSIP2, PF11_0442, and PF14_0633 (De Silva et al.,
2008; Flueck et al., 2010; Yuda et al., 2010; Yuda et al., 2009),
were dissected into overlapping sections of 200 amino acids
(Figure 1A), each fused to the C terminus of the GAL4 DNA-
binding domain (GAL4-DBD), to test for transactivation. As
a positive control, we used Aintegumenta (ANT), a well-charac-
terized plant AP2 transcriptional activator involved in the floral
development of Arabidopsis thaliana (Krizek and Sulli, 2006).
The fusions were first tested for lacZ expression with a yeast
colony-lift filter assay (data not shown). Activating domains
(ADs) found to be functional were then assessed quantitatively
with a liquid b-galactosidase assay (Figure 1B and Figure S1
available online). Functional sections were further divided into
shorter, overlapping peptides and examined again. Among the
eleven constructs tested in the liquid assay, a peptide
comprising 89 amino acids from the seventh section of PfSIP2,
termed PfSIP2_7.3, was the strongest activator, while
PfSIP2_6.1 and PfSIP2_4.1.5 were also clearly above back-
ground (Figure 1B). To determine whether transactivation in
yeast was dependent on the PfSIP2_7.3 AD sequence or on
the overall amino acid composition, we tested a randomized
peptide with scrambled amino acids (PfSIP2_7.3 RAND), and it
showed no activity (Figures 1B and S1B). Sequences derived
from PF11_0442 and PF14_0633 subdivisions did not strongly
transactivate in yeast (Figure 1B).
Recognizing that the evolutionary distance of yeast could
make it a suboptimal model to identify transactivation
sequences for Plasmodium, we turned to T. gondii to test a panel
of candidate sequences. Gene fusions between TetRep and
putative ADs (TRADs, Figure 1C) were created with a conserved
domain found in TGME49_016220 (TRAD1) and PbAP2O
(TRAD2)—both structural orthologs of PF11_0442 (Fig-
ure S1C)—that was inactive in the yeast assay. We also tested
the AD from ANT (TRAD3) and the PfSIP2_7.3 fragment
(TRAD4), which were both active in the yeast assay, and as-
sessed the expression of LacZ under the control of a tet transac-Cell Host &tivator-responsive promoter in T. gondii transiently transfected
with the different TRAD constructs (Meissner et al., 2002). Trans-
activation and inducibility were determined by X-Gal staining
(Figure S1D) and compared quantitatively with a colorimetric
assay (Figure 1D). All TRADs transactivated similarly or better
than the reference transactivator TATi-1 (Meissner et al., 2002),
with the exception of the TRAD2 construct containing the AT-
rich sequence of PbAP2O, which was not expressed at a detect-
able level in T. gondii (Figure 1E). In contrast, the complementary
DNA coding for the PfSIP2_7.3 domain in TRAD4 was codon
optimized for expression in T. gondii and was highly active.
Importantly, upon addition of ATc to the cultures, transactivation
by TRAD1, TRAD3, and TRAD4 was greatly suppressed. Since
the randomized PfSIP2_7.3 ADwith scrambled amino acids opti-
mized for yeast (ran-TRAD4-Sc) could not be expressed in
T. gondii (Figure 1E), we synthesized another AD with the same
sequence but optimized for expression in T. gondii (ran-
TRAD4-Tg). Intriguingly, ran-TRAD4-Tg was both expressed
and found to be as active as TRAD4 (Figure 1D), suggesting
that, unlike in the yeast experiments above, amino acid compo-
sition rather than sequence may be important for transactivation
by this peptide in T. gondii. We note that asparagine is signifi-
cantly overrepresented in TRAD4, accounting for 29% of the
amino acids. Previous work in yeast has demonstrated that
strong transactivating sequences are rich in acidic amino acids,
glutamine, proline, or asparagine, suggesting that elevated Asn
may similarly play a role in T. gondii transcriptional activation (An-
sari et al., 2001; Titz et al., 2006). However, the overall amino acid
composition of other TRADs in T. gondii did not share striking
amino acid compositional bias (Figure S1E) or predicted
secondary structures (data not shown).
Validation of the ApiAP2 Transactivators in P. berghei
and P. falciparum Blood Stages
TRADs found to be active in T. gondiiwere next assessed in ma-
laria parasites through the use of a plasmid designed to have
tet-regulatable transcription of GFP with the pMSP2-TRAD-
TetO7CAM-gpiGFP plasmid (Figure 2A) (Meissner et al., 2005).
When plasmids were maintained as stable episomes in
P.berghei, all four TRADconstructswereexpressedas functional
transactivators, resulting in ATc-dependent expression of a
gpiGFP reporter gene (Figure 2B). Using these same constructs,
we tested the activity of TRAD1 and TRAD4 compared to TATi-2
in the erythrocytic stages of the human malaria parasite
P. falciparum and found that they similarly were able to mediate
ATc-dependent expression of the gpiGFP reporter (Figure 2B).
Episomal plasmids are known to vary in copy number between
individual parasites, which is incompatible with reproducible
and homogenous cellular responses to ATc. We therefore inves-
tigated whether the TRAD fusions would still provide sufficient
transactivation and control when stably integrated into the
genome as a single copy gene. Transgenic parasite clones
were generated with vectors designed to replace the redundant
p230p gene (PBANKA_030600) of P. berghei (Janse et al.,
2006a) by double homologous recombination. The resulting
insertions contain a single copy of a cassette expressing different
TRAD constructs under the control of the strong constitutive
eef1aa promoter that is active throughout the life cycle of
P. berghei, including the insect and hepatic stages (Figure 2C).Microbe 12, 824–834, December 13, 2012 ª2012 Elsevier Inc. 825
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Figure 1. Identifying ApiAP2 Protein Fragments that Activate Transcription
(A) Strategy to functionally map AP2 activation domains in yeast. DNA binding domains (AP2motif) are shown in purple; transactivation domains (ADs) can only be
identified functionally. Full-length PFF0200c/PfSIP2, PF11_0442, and PF14_0633 were dissected into sections of200 amino acids (aa) shown in blue or yellow.
Yellow sections tested positive for activation by colony-lift filter assay (see Table S1 for results).
(B) A liquid colorimetric assay quantifying b-galactosidase in transiently transfected yeast was used to narrow down transactivation domains further. The empty
cloning plasmid (pGBT9) and a section of PFSIP2 (PfSIP2_10) were used as negative controls and were negative in filter assay. AtANT was used as positive
control. Error bars show standard deviations of three technical replicates.
(C) Schematic representations of the TetRep-AD fusion proteins TRAD1–TRAD4 and of the full-length ApiAP2 proteins from which their ADs were derived.
Putative ADs are shown in yellow, AP2 domains in purple, TetRep in orange, and Ty epitope tags in black. Expected molecular sizes are noted.
(D) b-galactosidase activity in the TetO7-LacZ strain of T. gondii transiently transfected with TRAD expression constructs. Cells were grown for 48 hr in the
presence or absence of ATc prior to quantification of LacZ expression with CPRG, as described (Meissner et al., 2001). The vertical axis reports b-galactosidase
activity as a percentage of TATi-1-driven activity in the absence of ATc. *A synthetic version by remodeling the codons (z50% AT) has been generated for
expression in T. gondii. **The endogenous AT-rich Plasmodium sequence is not expressed in T. gondii. Error bars show the SD of three replicates from four
independent experiments.
(E) Western blot showing the expression levels of the different TRADs, relative to PRF in T. gondii. TRAD2 and ran-TRAD4-Sc are not expressed due to the AT rich
codons. Note that the synthetic version of ran-TRAD4-Sc runs at the expected size when TRAD4 run aberrantly at 43 kDa.
See also Figure S1.
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A Repressible Plasmodium Expression SystemIn these reporter cassettes, an inducible promoter composed of
seven tet operators and a minimal promoter from the calmodulin
gene of P. falciparum controls the expression of amCherry gene.
Nine parasite lines with confirmed integration of different TRAD826 Cell Host & Microbe 12, 824–834, December 13, 2012 ª2012 Elsconstructs were cloned by limiting dilution. Schizonts cultured
in the presence or absence of ATc were analyzed for mCherry
expression by flow cytometry, and the fluorescence intensity
was compared to a parasite line in which the reporter wasevier Inc.
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Figure 2. Testing of the ApiAP2 Transactivators in Plasmodium
(A) Schematic illustrating a transfection plasmid for episomal expression in P. berghei and P. falciparum. The constructs used are derived from the previously
described pMSP2-TATi2-TetO7CAM-iGFP plasmid (Meissner et al., 2005), with TATi2 replaced by the different TRADs. TRADs are under the control of a PfMSP2
promoter, and a gpi-anchored GFP reporter is under the control of a tet transactivator-responsive promoter containing seven tet operator sites.
(B) Western blot analysis of gpi-GFP expression in schizonts transiently transfected with TRAD reporter constructs as shown in (A). Infected mice were treated
with ATc for 36 hr before parasites were collected and cultured into schizonts in vitro for 14 hr in the presence of 1 mg/ml ATc. P. falciparum synchronized cultures
were treated with ATc for 48 hr and the schizonts collected. Profilin was used as loading control. Representative data from two experiments are shown.
(C) Transfection vectors used to integrate TRAD expression cassettes with and mCherry reporter gene into the p230p locus by irreversible ends-out recombi-
nation.
(D) Analysis by flow cytometry of the effect of ATc onmCherry fluorescence intensity in purified schizonts expressing ran-TRAD4.Wild-type schizonts and a clone
carrying a stable, single-copy integration of mCherry expressed directly from the eef1aa promoter served as controls. Data shown are representative of three
experiments.
(E) Mean mCherry fluorescence intensity of schizonts carrying the constructs shown in (C) and cultured in the presence or absence of ATc. ATc was applied to
infected mice and cultures as in (B). Error bars show the SD of three independent experiments. *p < 0.01 relative to TetRep. **p < 0.01 relative to both TetRep and
TATi2.
(F) Total mCherry fluorescence of individual exoerythrocytic forms (EEFs) in Hepa 1–6 mouse hepatoma cells at 50 hr p.i. is plotted against parasite area as
quantified from automatically acquired images. Black lines show second-order polynomial curve fits (r2 = 0.64-0.75). Data are representative of two experiments.
(G) Average mCherry fluorescence intensity of EEFs >100 mm2 is expressed as a percentage of the control line expressing mCherry under the eef1aa promoter
without ATc. Error bars show the SD of two experiments, each measuring 50–100 EEFs for each condition.
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Single copies of TATi2, TRAD1, TRAD2, TRAD3, and TRAD4
each resulted in expression of mCherry (Figure 2E). Tati2,Cell Host &TRAD2, and TRAD4 activated significantly stronger than TetRep
without a transactivation domain. TRAD4 showed improved
transactivation when compared to the previously identifiedMicrobe 12, 824–834, December 13, 2012 ª2012 Elsevier Inc. 827
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A Repressible Plasmodium Expression SystemTATi2 peptide. As a control, the TRAD4 peptide failed completely
to transactivate in a construct lacking the tet operators upstream
of the minimal promoter (TRAD4 with no TetO7), demonstrating
that the TRADs act as genuine transactivation sequences in
P. berghei.
Interestingly, transactivation by the sequences from T. gondii
(TRAD1) and A. thaliana (TRAD3) was comparable to a tet
repressor lacking any transactivation sequence (TetRep only),
while both Plasmodium-derived sequences (TRAD2 and
TRAD4) enhanced transactivation. As in T. gondii, a randomized
TRAD4 peptide produced marked transactivation, which in the
case of P. berghei was even stronger than that mediated by
TRAD4 itself. In the presence of ATc, fluorescence of all TRAD
reporter lines was strongly repressed to almost wild-type (WT)
background levels. These data show that in P. berghei blood
stages, TRAD2, TRAD4, and ran-TRAD4 allow different levels
of transgene expression to be controlled by ATc.
Examination of the Transactivation in P. berghei
Mosquito and Liver Stages
We next assessed whether tet-regulatable expression would
persist in the mosquito stages. On day 7 postinfection (p.i.),
mCherry fluorescence intensity of ran-TRAD4-Sc oocysts
reached 32% ± 3% of the eef1aa control parasites, suggesting
that transactivation occurred. However, ATc failed to reduce
fluorescence when added to the fructose solution for 3 days
from day 6 p.i., during a period of rapid oocyst growth (data
not shown). Similarly, ATc treatment during the 3 days preceding
analysis affected mCherry fluorescence neither of day 12
oocysts nor of salivary gland sporozoites at 26 days p.i. Impor-
tantly, however, when ran-TRAD4-Sc salivary gland sporozoites
were used to infect mouse hepatoma cell cultures, addition of
ATc to the culture medium from 3 hr p.i. repressed mCherry
expression as determined by automated microscopy and image
analysis at 50 hr p.i. (Figures 2F and 2G). These data show that
for the system described here to be useful in mosquito stages
in vivo, either its genetic components or the delivery of ATc to
the mosquito require further optimization, but that in liver stages
ran-TRAD4-Sc provides an effectivemeans of regulating expres-
sion of a transgene.
Knockdown of Essential Genes
We next asked whether a TRAD4-based ATc-repressible trans-
activator system could be used to conditionally knock down pro-
filin (prf, PBANKA_083300) and N-myristoyltransferase (nmt,
PBANKA_102980) genes, which are both predicted to be essen-
tial to Plasmodium development in asexual blood stages.
Previous studies have established the importance of PRF as
a regulator of actin dynamics in invasive stages of Apicomplexa
(Baum et al., 2008; Kursula et al., 2008; Plattner et al., 2008). In
T. gondii, PRF is not only essential for gliding motility, host cell
invasion, and egress, but also acts as a modulator of the host
immune response via TLR11 (Kursula et al., 2008; Plattner
et al., 2008). A double crossing over recombination strategy
was used to position TRAD4 upstream of the endogenous
P. berghei prf promoter, while the coding sequence of prf was
brought under the control of the inducible promoter containing
the tet operator. Simultaneously, two HA epitope tags were
placed at the N terminus of the resulting inducible copy of prf828 Cell Host & Microbe 12, 824–834, December 13, 2012 ª2012 Els(Figure 3A). Several independent transgenic pools were obtained
(five different transfections were attempted, and all resulted in
positive transgenics pools), cloned, and assessed by genomic
PCR (Figure 3B). Expression of TRAD4 as well as the ATc-
induced depletion of HA-PRF were confirmed by western blot
(95%downregulation compared toWT and 90%downregulation
compared to the untreated prf-iKO) (Figures 3C, S2A, and S2B).
In mice infected with prf-iKO parasites in the absence of ATc, the
rise in parasitaemia was indistinguishable from WT infections in
the presence of ATc (Figure 3D). In contrast, an extremely low
parasitaemia was detected with prf-iKO in the presence of ATc
(Figure 3D). In addition, we observed a modification of stage
composition of prf-iKO parasites depleted in PRF in peripheral
blood (Figure S2C), with a decreased proportion of ring stages
and the appearance of circulating mature segmented schizonts.
While the latter points to a defect in egress, the former would also
be consistent with an invasion phenotype. Consistent with this,
when we exposed prf-iKO parasites to ATc for 24 hr in mice
and then continued this treatment for 14 hr in vitro, morphologi-
cally mature schizonts were formed (Figure 3E), suggesting that
intraerythrocytic development was not visibly affected.
For examination of whether prf-iKO parasites had an invasion
defect, mature schizonts were purified, labeled, and mixed with
uninfected red blood cells (RBCs) that had been treated with
a fluorescent cell tracer. Schizonts were then ruptured mechani-
cally by vigorous shaking, andmerozoiteswere allowed to invade
the labeled targetRBCs in vitro.Newly invadederythrocyteswere
identified and counted by fluorescence-activated cell sorting
(FACS) as cells that combined the parasite DNA label with the
tracer dye of the host cell (Theron et al., 2010). The number of
newly invaded erythrocytes produced from the same number of
morphologically mature schizonts was reduced by 60% upon
ATc treatment of prf-iKO parasites (Figures 3F and S2D). While
these data cannot distinguish between phenotypes affecting
either forced egress or invasion, they confirm and explain the
alteredstagecompositionofprf-iKOparasites inperipheral blood
in presence of ATc (Figure S2C) and suggest that PRF plays an
important role at around the time P. berghei transitions from
one erythrocyte to the next. This is consistent with the reported
role for PRF during invasion and egress in T. gondii (Plattner
et al., 2008). Knockdown of prf had no effect on gametocyte
production (Figure S2E), and microgametocytes from treated
mice released gametes effectively when stimulated in vitro (Fig-
ure S2F). When gametocytes from treated mice were stimulated
to form gametes and then cultured in the continued presence of
ATc, PRF levels in ookinetes (Figures S2G and S2H) were
reduced and the rate at which ookinetes arose frommacrogame-
tocytes (Figure S2H) was halved, suggesting that PRF has an
additional function in fertilization or ookinete development.
Taken together, these results demonstrate that (1) TRAD4 can
drive prf expression to a level compatible with normal parasite
growth, (2) depletion of HA-PRF upon ATc treatment is sufficient
to reveal a clear growth phenotype in vivo, and (3) ATc treatment
of ookinetes cultured in vitro can reveal phenotypes during
zygote and ookinete development.
The second essential gene that we targetedwas theP. berghei
nmt, which catalyzes the transfer of myristate from myristoyl-
CoA to the amino-terminal glycine residue on numerous cellular
proteins, many of which are subsequently modified byevier Inc.
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Figure 3. Generation of a prf Knockdown in P. berghei
(A) Schematic representation of the strategy used to construct prf-iKO parasites. A recombination event occurs in the prf promoter to place the TRAD4 trans-
activators under the control of the prf promoter, the second within the prf coding sequence to add two N-terminal HA tags and hence placing the tagged full-
length prf under the control of the Tet-responsive promoter.
(B) PCR analysis to confirm that double homologous recombination occurred; PCRs on one representative clone are shown.
(C) Western blot analysis of schizont lysates for PRF and TRAD4 expression showing the ATc-regulated expression of HA-PRF (both with anti-PfPRF and anti-HA
antibodies). The inducible copy of PRF migrates slightly slower due to the double HA tag. Actin serves as loading control. The TRAD4 expression is revealed with
anti-Ty antibodies.
(D) Parasitaemia in mice that were treated or not with ATc in the drinking water from 2 days prior to infection. Error bars show the SD of six mice per condition.
(E) Giemsa-stained blood smears showing normal development of prf-iKO parasites to the schizont stage in vitro. Mice were infected with WT and prf-iKO
parasites and treated or not with ATc for 24 hr before parasites were cultured in vitro for the times indicated. Error bars show SD of three independent exper-
iments.
(F) Invasion phenotype of prf-iKO parasites. Vybrant Green-labeled purified schizonts were incubated with DDAO-SE-labeled RBCs, and the merozoites were
allowed to invade. Parasitaemia in the DDAO-SE-labeled target population was determined by flow cytometry. Invasion efficiencies were determined as
a percentage of the WT control parasites. Cytochalasin D (CD)-treated schizonts were used as a negative control. Data are represented as mean ± SD of three
independent experiments.
See also Figure S2.
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A Repressible Plasmodium Expression Systempalmitoylation (Sorek et al., 2009). Myristoylation of proteins is
a crucial regulatory mechanism implicated in a great variety of
biological processes, and consequently NMT is essential for
viability in all cell types tested to date. Notably, NMT has recently
been reported as an attractive novel drug target against the
protozoan parasites T. brucei and Leishmania donovani (Bran-
nigan et al., 2010; Frearson et al., 2010), which potentially
extends to the Plasmodium species (Bowyer et al., 2007;
Rees-Channer et al., 2006). Using a similar strategy as described
for prf above, we generated a conditional disruption of the nmt
gene (Figure S3A). Promoter replacement and regulation by
ATc were confirmed by quantitative PCR and western blot anal-
ysis of nmt-iKO clones (Figures 4A and S3B–S3D). In vivo devel-
opment of two nmt-iKO clones was severely impaired in the
presence of ATc. After intravenous injection of equal numbers
of parasitized erythrocytes, ATc treatment of mice delayed the
appearance of a detectable parasitaemia from day 2 to day 8
p.i. From day 8, only four out of ten treated mice developed
a detectable and increasing parasitaemia, suggesting thatCell Host &a small fraction of parasites escaped the ATc treatment. By
isolating these surviving parasites, we found that they had lost
regulation of HA-NMT expression by ATc (Figure 4A), an in vivo
phenomenon that has also been observed with the Tet system
in T. brucei. The nmt-iKO parasites harvested from mice after
24 hr treatment with ATc were assayed for intraerythrocytic
development in vitro. While the morphology of the ring stages
collected from themice was normal, thematuration was severely
impaired, resulting in the appearance of aberrant trophozoites
and schizonts (Figure 4C). Given the severity of the phenotype,
we repeated the experiment by pretreating the mice with ATc
for only 12 hr instead of 24 hr before the parasites were collected
and taken into culture. At this point, nmt-iKO parasites isolated
fromATc treatedanduntreatedmice showednodifference inpar-
asitaemia or morphology. After 14 hr of in vitro culture, the para-
sites that had been treated with ATc in mice for 24 hr failed to
develop normally, irrespective ofwhether ATcwaspresent during
the subsequent culture period. In contrast, parasites exposed to
ATc for only 12 hr in the mice were then able to recover and formMicrobe 12, 824–834, December 13, 2012 ª2012 Elsevier Inc. 829
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
20 
0 1 2 3 4 5 6 7 8 
P
ar
as
ita
em
ia
 %
 
Days post infection 
WT + ATc 
nmt-iKO Cl.1 
nmt-iKO Cl.1 + ATc 
nmt-iKO Cl.3 
nmt-iKO Cl.3 + ATc 
B A
55 
43 
34 
26 
ATc    -    -    +    +          -    -   +   +   
kDa 
72 
PRF 
TRAD4 
HA-NMT
Anti-HA tag 
Anti-Ty tag 
Anti-PRF 
C 
WT + ATc nmt-iKO nmt-iKO + ATc
0 h
6 h
9 h
14 h
Figure 4. Generation of a nmt Knockdown in P. berghei
(A) Western blot analysis of mixed asexual blood stages, showing that HA-NMT is expressed and initially regulated by ATc. Protein expression in parasites from
mice treated with ATc for 36 hr is compared with that in ATc resistant parasites that emerged after 8 days of continuous treatment. TRAD4 is detected by anti-Ty
antibodies and PRF serves as loading control.
(B) Parasitaemia in mice that were treated or not with ATc in the drinking water from 2 days prior to infection. Error bars show standard deviations of 5 mice per
parasite clone.
(C) Giemsa-stained blood smears of in vitro maturedWT and nmt-iKO parasites. To assess intraerythrocytic development, infected mice were treated or not with
ATc for 24 hr before parasites were cultured in vitro for the times indicated. Data are representative of 3 experiments. The intra-erythrocytic development is
severely perturbed and disorganized (arrow), resulting in aberrant schizonts with only a few small merozoites (arrow-head). Data are representative of 2
experiments.
See also Figure S3.
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A Repressible Plasmodium Expression Systemmature schizonts in the absence of ATc in culture, whereas the
continued presence of ATc resulted in a mixed population of
mature schizonts and arrested/abnormal parasites.
Transcriptome data (Bozdech et al., 2003) indicates that
Pbnmt expression increases during the ring stage of the erythro-
cytic cycle, which requires 24 hr for completion. It is plausible
that after 24 hr treatment with Atc in mice, all ring stage parasites
and parasites that progress through a full cycle back to ring
stage have been depleted of NMT and thus fail to develop. After
only 12 hr treatment, however, only parasites at ring stage are830 Cell Host & Microbe 12, 824–834, December 13, 2012 ª2012 Elsdepleted, so trophozoites and early schizonts that have passed
the ring stage bottleneck can develop normally in culture even in
presence of ATc (Figure S3F). Approximately 50 proteins are pre-
dicted substrates for NMT inP. falciparum (Jones et al., 2012), so
downregulation of NMT most likely affects numerous cellular
functions in the parasite.
Conclusion
The identification of highly functional transactivating domains
has allowed us to develop a robust Tet-repressibleevier Inc.
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A Repressible Plasmodium Expression Systemtransactivator system that is well suited for the study of genes
essential for the red blood stages of P. berghei development.
This regulatable system will allow the direct validation of candi-
date drug targets to combat malaria, as highlighted by our
results with NMT. Although all proof-of-principle data for the
prf and nmt genes were obtained using TRAD4 in P. berghei,
this study provides a panel of transactivation sequences of
varying strengths, which will be useful to achieve tailored levels
of regulatable gene expression. Of course, optimizing the system
to P. falciparum is another major goal. Data presented here show
that for P. falciparum, TRAD4—and to a lesser extent TRAD1—
transactivates conditionally when expressed from an episomal
plasmid in the asexual blood stages. However, further work is
required to investigate whether any of the TRADs identified
here are superior to TATi2 when integrated as single copies
into the genome of the human parasite. Another remaining chal-
lenge is to apply this system to essential genes in the mosquito
and liver stages of the Plasmodium life cycle. While our initial
analysis of a prf-iKO indicates that TRAD4 transactivates condi-
tionally in ookinetes, our attempts to regulate expression of
mCherry at the oocyst and sporozoite stageswere unsuccessful,
highlighting the need to optimize either the genetic system or the
delivery of ATc tomosquitoes. For such studies, it may be neces-
sary to rear mosquitoes on a larval diet free from tetracycline
antibiotics that could interfere with the expression system
when carried over into the adult mosquito. Ran-TRAD4-Sc al-
lowed for conditional transactivation in P. berghei liver stages;
thus, the Tet system could potentially be utilized to study gene
function at this stage.EXPERIMENTAL PROCEDURES
Identification and Testing ofPlasmodium falciparumApiAP2 Protein
Fragments for Their Ability to Activate Transcription in Yeast
To identify putative functional transactivating regions in the ApiAP2 family of
transcription factors, we dissected the PFF0200c (pfsip2), PF14_0633, and
PF11_0442 genes into regions encoding 200 amino acids and cloned these
fragments. We focused on these three ApiAP2 genes because all three have
been characterized and reported in the literature and contain functional AP2
domains that bind specific DNA sequence motifs (Campbell et al., 2010).
The P. berghei homologs of PF11_0442 (PBANKA_090590) and PF14_0633
(PBANKA_123980) have been shown to be essential developmental regulators
in the mosquito stage (Yuda et al., 2010; Yuda et al., 2009). We noted that
PF11_0442 also has a region of homology outside of the AP2 domain with
Toxoplasma gondii protein TGME49_016220 and other Plasmodium species.
In addition, the protein alignment of these orthologs shows that the N- and
C-terminal ends of PF11_0442 are not conserved in TGME49_016220. We
therefore only tested the aligned regions excluding the tails present in Plasmo-
dium (Table S1). Finally, PFF0200c (PfSIP2) has been demonstrated to act as
a scaffolding protein to recruit additional proteins to the subtelomeric regions
of P. falciparum chromosomes (Flueck et al., 2010). As a positive AP2 control,
we used the A. thaliana protein Aintegumenta (ANT), because it has already
shown to activate transcription in this system and the activating domain was
mapped precisely (Krizek and Sulli, 2006). We also tested two synthetic trans-
activators, TATi-1 and TATi-2, which have previously been shown to function in
T. gondii (Meissner et al., 2002) and in P. falciparum (TATi-2 only) (Meissner
et al., 2005).
Protein alignments against orthologs from other apicomplexan species were
used to guide our selection of fragments in order to avoid disrupting any
regions of homology. PCR primers were designed to introduce restriction sites
(EcoRI and SalI) at the section ends for cloning into pGBT9 (gift from Beth Kri-
zek) (Krizek and Sulli, 2006). The final constructs were transformed into Es-
cherichia coli strain DH5a and encode fusions to the C-terminal end of theCell Host &GAL4 DNA binding domain (GAL4-DBD). PCR-positive clones were purified
(QIAGEN) and were confirmed by DNA sequencing. Recovered plasmids
were subsequently transformed into the yeast strain HF7c [MATa, ura3–52,
his3–200, lys2–801, ade2–101, trp1–901, leu2–3, 112, gal4–542, gal80–538,
LYS2::GAL1–HIS3, URA3::(GAL4 17mers)3–CYC1–lacZ] (gift fromBeth Krizek)
to test for transactivationwith aone-hybrid system.Yeast competent cell trans-
formation used amodified lithium acetate procedure (Gietz et al., 1992). Trans-
formed cells were plated on SD/-Trp plates and grown for 3 days at 30C. We
first qualitatively assayed all of our yeast strains for activation of a lacZ gene
reporter using a colony-lift filter assay to screen for the production of the
enzyme b-galactosidase using X-gal (Breeden and Nasmyth, 1985).Refinement of the Activation Sequences
Since PfSIP2_4, PfSIP2_6, PfSIP2_7, and PF11_0442_5 activated transcrip-
tion in a yeast colony-lift assay, we subdivided each of these into three over-
lapping sections of 85 amino acids each. The first of the subdivisions
spanned the first half of the section, the third subdivision spanned the second
half of the section, and the second subdivision completely overlapped the two
to ensure that the activation domain was not interrupted (e.g., PfSIP2_7.1,
PfSIP2_7.2, and PfSIP2_7.3; see Figure 1A). These sections were cloned
into pGBT9 as described above and retested for transcriptional activation in
the colony-lift assay. PfSIP2_4.1, PfSIP2_4.2, PfSIP2_6.1, and PfSIP2_7.3 all
produced positive results. Since PfSIP2_4.1 and PfSIP2_4.2 were both able
to activate transcription, this indicated that the region of overlap between
the two sections contained the activation sequence. Therefore, a smaller 54
amino acid region (PfSIP2_4.1.5) was also tested, and it was able to activate
transcription. Therefore, PfSIP2 provided us with three functional transactivat-
ing regions. In contrast, all subdivisions of PF11_0442_5 failed to activate tran-
scription, so the section was kept whole for further testing.
For those yeast clones that performedwell in the colony-lift assay, we further
tested them using a quantitative liquid chlorophenolred-b-D-galactopyrano-
side (CPRG) assay to compare b-galactosidase activity (Miller, 1992). We
also generated a randomized version for one of the functional protein
segments (PFF0200c_7.3) to determine whether activation was specific to
the protein sequence or overall amino acid content. To do this, we wrote
aMATLAB code to randomize the input sequence (Figure S3), which we codon
optimized for expression in S. cerevisiae (PFF0200c_7.3_RAND). This gene
was synthesized by DNA2.0 and cloned into pGBT9 as described above.
The following 11 constructs were tested in the liquid assay: ANT,
PFF0200c_7.3, PFF0200c_7.3_RAND, PFF0200c_6.1, PFF0200c_4.1.5,
PFF0200c_10, PF11_0442_5, PF14_0633_3, PF14_0633_4, TATi-2, and the
plasmid pGBT9 with no insert. ANT was used as a positive control, and
pGBT9, TATi-2, and PFF0200c_10 were used as a negative control.
b-galactosidase units were calculated with the formula
b-galactosidase units=
10003OD578
ðt3V3OD600Þ;
where t = elapsed time (in min) of incubation, V = 0.1 3 concentration factor
(V = 0.5 in this study), and OD600 = A600 of 1 ml culture.Parasites and Mosquitoes
A T. gondii RH strain expressing HXGPRT and LacZ under the control of a tet
transactivator-responsive promoter (Meissner et al., 2001) was used to vali-
date the ApiAP2 transactivators in T. gondii. T. gondii tachyzoites were grown
in human foreskin fibroblasts (HFFs) or Vero cells in Dulbecco’s Modified
Eagle’s Medium (DMEM) (GIBCO BRL, http://www.invitrogen.com/) supple-
mented with 10% fetal calf serum (FCS), 2 mM glutamine, and 25 mg/ml
gentamicin.
All P. berghei parasites are derivatives of clone 2.34 of the ANKA strain.
Ookinetes were produced in vitro by culturing of gametocyte-infected mouse
blood in ookinete medium (RPMI1640 containing 25 mMHEPES [Sigma], 10%
FCS, and 100 mM xanthurenic acid [pH 7.5,] with or without ATc at 1 mg/ml) for
24 hr at 19C, and conversion assays were performed by live staining of
ookinetes and activated macrogametes with Cy3-conjugated monoclonal
antibody 13.1 against the P28 surface protein. The conversion rate from
macrogametes into ookinetes was determined as the number of elongate
ookinetes as a percentage of the total number of Cy3-fluorescent cells.Microbe 12, 824–834, December 13, 2012 ª2012 Elsevier Inc. 831
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lowed to feed on female Theiler’s Original (TO) outbred mice 3 days after intra-
peritoneal injection of infected blood. Unfed mosquitoes were removed the
day after, and mosquitoes were maintained on 8% fructose/water at 19C.
Oocysts were imaged on dissected midguts 9 and 12 days after feeding
with a M205FA stereomicroscope and LAS AF software equipped with
a DFC340 FX monochrome camera (all from Leica). mCherry fluorescence
intensity of oocysts was analyzed with the SpotDetector BioApplication image
analysis software (ThermoFisher). Sporozoites isolated from infected salivary
glands at 26 days p.i. were imaged with a DM2500 widefield microscope (Le-
ica) for quantification. For in vitro sporozoite infections, Hepa 1–6 (ATCC CRL-
1830) mouse hepatoma-cells were cultured in DMEM high glucose (GIBCO/
Invitrogen) with 10% FCS (Tet System Approved Serum, Clontech) at 37C
with 5%CO2. For sporozoite infection (the protocol was adapted from Prudeˆn-
cio et al. [2008]), Hepa 1–6 cells were seeded on 96-well cell culture plates
(10,000 cells per well) and cultured for 24 hr. Twenty thousand eef1aa or
ran-TRAD4-Sc isolated salivary gland sporozoites were added to the cells in
DMEM, 10% FCS, and 1% pen/strep. At 3 hr p.i., the medium was exchanged
for fresh medium with or without 1 mg/ml ATc and kept in the dark in the incu-
bator. At 50 hr p.i., the cell nuclei were counterstained with Hoechst 33342
(0.2 mM, Molecular Probes/Invitrogen) in fresh medium (no ATc), and the plate
was placed inside a life cell chamber (37C with 5% CO2). The images of wells
were automatically acquired with a Cellomics ArrayScan VTI HCS Reader
(203; 100 fields per well) and analyzed with the SpotDetector BioApplication
(all from ThermoFisher) for mean fluorescence intensity of parasites.
P. falciparum strain 3D7 was grown in A+ erythrocytes in RPMI-1640
medium with glutamine (Life Technologies, http://www.invitrogen.com/),
0.2% sodium bicarbonate, 25 mM HEPES, 0.2% glucose, 5% human serum,
and 0.1% Albumax II (Life Technologies). Parasites were synchronized by
a double sorbitol treatment as previously described (Lambros and Vander-
berg, 1979).
T. gondii and P. berghei and P. falciparum Transfection
All animal work was conducted under a license issued by the Swiss Veterinary
Office in accordance with cantonal and international guidelines. Transient
transfections of T. gondii strain were undertaken as previously described (Sol-
dati and Boothroyd, 1993). Stable transformants were selected for expression
of hDHFR. P. berghei erythrocytic stages were transfected by electroporation
with Amaxa technology as previously described (Janse et al., 2006b).
P. falciparum erythrocytic stage parasites were transfected as previously
described (Crabb et al., 2004). Transfection of Plasmodium clones 3D7 were
carried out by electroporation, and selection was achieved by treatment of
parasites with 5 nM of WR99210 for human dhfr-based plasmids.
P. berghei mCherry FACS Analysis
Schizonts cultured for 24 hr in vitro were purified with a Nycodenz cushion and
stained for 15 min with Hoechst 33342 DNA dye (Invitrogen). Cells were
analyzed with the 488 nm and 355 nm laser lines of a BD LSR Fortessa flow
cytometer (BD Biosciences). mCherry fluorescence was detected by a
610/20 filter and Hoechst by a 450/50 filter. BD FACSDiva software (BDBiosci-
ences) was used to collect 10,000 events for each sample. The data collected
was further analyzed with FlowJo (Tree Star). The schizont population was
identified by Hoechst stain, and average mCherry fluorescence was then
determined in the gated schizont population.
P. berghei Invasion Assay
The invasion assay was adopted from that described for P. falciparum by
Theron et al. (2010). Schizonts cultured for 16 hr in vitro were purifiedwith aNy-
codenz cushion, and parasite DNAwas stainedwith Vybrant Green (Invitrogen)
according to the manufacturer’s recommendations. Target erythrocytes were
labeled with the amine-reactive fluorescent dye DDAO-SE (Invitrogen) accord-
ing to the manufacturer’s instructions. Labeled parasites and target RBCs
were mixed at ratio 1/100, schizonts were then ruptured mechanically by
vigorous shaking, and merozoites were allowed to invade in vitro for 20 min.
As a control, schizonts were treated with cytochalasin D (CD) to inhibit inva-
sion. Schizont rupture and invasion were confirmed on Giemsa-stained blood
smears. Samples were then fixed (paraformaldehyde 2%, glutaraldehyde
0.05%) and analyzed by FACS (FACSCalibur, BD). Vybrant Green was de-832 Cell Host & Microbe 12, 824–834, December 13, 2012 ª2012 Elstected by a 530/30 filter and DDAO-SE by a 661/16 filter. The data collected
were further analyzed with FlowJo (Tree Star). The parental parasite population
was identified by Vybrant Green stain, the target RBCs by DDAO-SE stain, and
the newly invaded erythrocytes by Vybrant Green and DDAO-SE stain.
PCR Analysis of the prf and nmt Loci
Genomic DNA isolated from clones of pyrimethamine-resistant parasites
transfected or fromwild-type parasites was subjected to PCRwith the primers
indicated (Figure 4A and Table S1).
Infection of Mice with P. berghei Parasites
The blood stages of cloned lines of P. berghei were maintained as stabilates
(parasitized erythrocytes in Alsever solution) in liquid nitrogen. Mice were in-
fected intraperitoneally with 107 parasites. Parasitaemia was determined daily
by means of blood smears stained with Giemsa and a count of the number of
infected erythrocytes in at least 1,000 erythrocytes.
ATc Treatments
For in vivo treatment of mice, ATc (SIGMA) was dissolved in water + 5%
sucrose at a concentration of 0.2 mg/ml. The drinking water bottle was wrap-
ped in aluminum foil to prevent precipitation of ATc due to light and the solution
changed every 48 hr. For in vitro treatments, ATcwas diluted in culturemedium
at 1 mg/ml as previously described (Meissner et al., 2005). For tetracycline
treatment of mosquitoes, ATc was dissolved freshly in the fructose feeding
solution (8% fructose/water) at a concentration of 100 mg/ml and kept in the
dark, and the solution was exchanged every 24–48 hr. eef1aa- or ran-
TRAD4-Sc-infected mosquitoes were treated for 3 consecutive days before
dissection. For sporozoite-infected hepatoma cultures the culture medium
was exchanged at 3 hr p.i. for fresh medium with or without 1 mg/ml ATc and
kept in the dark in the incubator.
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